DIYbio: Low Risk, High Potential

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

Written byTodd Kuiken
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© HARRY CAMPBELLAs the do-it-yourself biology (DIYbio) community has grown, so too have the concerns about the potential dangers and reach of the DIYbio movement—in particular with regard to synthetic biology. A sampling of headlines in major newspapers and magazines over the past year include: “Amateurs Are New Fear in Creating Mutant Virus,” “D.I.Y. Biology, on the Wings of the Mockingjay,” and “Hacking the President’s DNA.” But much of this alarm is overblown, as critics overestimate the current abilities of the DIYbio movement and underestimate the ethics of its participants, who can range from PhD-trained scientists to the true amateur who has little professional training.

Furthermore, while concerned parties call for government oversight, the DIYbio community has already proven to be proactive in addressing biosafety and biosecurity concerns. In December 2011, Genspace, the first community laboratory to open in the United States, recruited an external advisory board of distinguished academic, government, and industry professionals to answer safety-related questions. The board also reviews the appropriateness of certain projects requiring a Biosafety Level 1 environment, ensures adherence to National Institutes of Health (NIH) recombinant DNA guidelines, and helps minimize the use of potentially hazardous reagents. For the larger DIYbio community, DIYbio.org and the Woodrow Wilson International Center for Scholars launched the “Ask a Biosafety Expert” web portal, which allows anyone to submit biosafety- and biosecurity-related questions to a panel of biosafety professionals ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies